Overview of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc (amlodipine) Trial: PREVENT

Canadian Journal of Cardiology

Volumn 16, Issue SUPPL. D, 2000, Pages

  Mancini, G B John ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Atherosclerosis; Calcium channel blockers; Clinical trials; Lesion

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT;

ANGIOCARDIOGRAPHY; CAROTID ARTERY DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; HUMAN; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

AMLODIPINE; CALCIUM CHANNEL BLOCKERS; CAROTID ARTERY DISEASES; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; HUMANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS;

EID: 0034222917     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Tulenko TN, Laury-Kleintop L, Walter MF, Mason RP. Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection? Int J Cardiol 1997;62(Suppl 2):S55-66.
2. Loaldi A, Polese A, Montorsi P, et al. Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris. Am J Cardiol 1989;64:433-9.
3. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators. Lancet 1990;335:1109-13.
4. Waters D, Lesperance J, Francetich M, et al. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1990;82:1940-53.
5. Byington RP, Miller ME, Herrington D, et al. Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT). Am J Cardiol 1997;80:1087-90.
6. Aminbakhsh A, Mancini GBJ. Carotid intima-media thickness measurements: what defines an abnormality? A systematic review. Clin Invest Med 1999;22:149-57.
7. Holmes C, Mancini GBJ. Angiographic results of lipid lowering trials: A systematic review and meta-analysis. In: Grundy S, ed. Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence. New York: Markel Dekker, Inc, 2000:191-220.